Navigation Links
ASU leads $5 million NIH-sponsored research initiative to advance diabetes care and treatment
Date:11/1/2011

inical studies to advance the difficult search for markers that may be useful for both diagnosis and for assessing potential new drug therapies."

The study will examine and validate biomarkers in people with diabetes, some of whom will have had a heart attack. It is unlikely that a single biomarker will have enough predictive power to assess heart attack risk; rather, panels of biomarkers will be needed to identify drug targets.

"There is a great need for more-effective biomarkers of macrovascular complications of diabetes and for surrogate indicators of favorable response to potential diabetes therapies," said Peter Reaven, M.D., who will oversee the selection of target biomarkers and clinical work, including patient recruitment at the Phoenix VA Health Care System. "Our goal is to identify novel proteins and relevant protein modifications that reflect many of the critical mechanisms that underlay vascular disease in diabetes to develop a more comprehensive panel of biomarkers. One advantage to our team approach is that it will integrate, from the very beginning, the many aspects and disciplines required for a pipeline of biomarker discovery, validation and translation." Pfizer will play a key role in translating prognostic biomarkers of cardiovascular disease risk for decision-making during drug development for type 2 diabetes.

"Prognostic markers of cardiovascular disease risk have been an essential need for type 2 diabetes drug development ever since Nissen published his influential report suggesting some drugs may increase heart attack rates," said Jim Pearson, Ph.D., head of Personalized Medicine at Pfizer in Kalamazoo, MI. "The FDA now requires patients with a higher risk for cardiovascular events to be enrolled in Phase III clinical trials for two years instead of three-to-six months. The problem is that a useful directed proteomics CVD risk panel has yet to be translated. A biomarker panel that is more comprehensive than HbA1c
'/>"/>

Contact: Joe Caspermeyer
joseph.caspermeyer@asu.edu
480-727-0369
Arizona State University
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Rise in Vulvar Precancers Leads to New Guidelines
2. Project leads next decade of aging research across Europe
3. Project leads next decade of ageing research across Europe
4. X-ray protein probe leads to potential anticancer tactic
5. Insulation from public pressure leads to more accurate suicide reporting by death investigators
6. Unconventional hunt for new cancer targets leads to a powerful drug candidate for leukemia
7. Stronger social safety net leads to decrease in stress, childhood obesity
8. Drug improves brain function in condition that leads to Alzheimers
9. Drinking until you forget leads to injuries for college kids
10. 2 talks with teens leads to less marijuana use for at least a year
11. FSU scientist leads research on AIDS-related cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
ASU leads $5 million NIH-sponsored research initiative to advance diabetes care and treatment
(Date:2/26/2015)... 2015 Deep Market Research Report on ... in-depth study on the current state of the ... focus on the Chinese situation. , Major companies ... Youji, Tongtai, Tenlong, Zhiyuan, MILAN, Dongda, Fengkang, Xindayu, ... , The report provides a basic overview of ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 As the ... are looking for deeper meaning, more substantial roles and ... – how do I live a life that still ... round of Younger Next Year Total Immersion Retreat ... This program boasts unbelievable results and jump-starts a healthier ...
(Date:2/26/2015)... Los Angeles, CA (PRWEB) February 26, 2015 ... to live stream his hair transplant contest winner’s ... and preparation, the winner Marc R., is all set to ... transplant using the ARTAS system. His procedure will be done ... Parsa Mohebi website. To watch the surgery, go to the ...
(Date:2/26/2015)... PartnerTech Inc . has announced it has been named ... , The Movers & Makers Awards are presented in ... distribution of tangible products and will be held on March ... as Georgia’s largest local awards ceremony for manufacturing and supply ... local industry and business leaders. , “We are thrilled ...
(Date:2/26/2015)... In a nested-case control study of individuals ... a relatively low incidence of liver cancer, statin use is ... to a new study published February 26 in the ... studies have reported this association but most used data from ... rate, such as Asia. Katherine A. McGlynn, Ph.D., from the ...
Breaking Medicine News(10 mins):Health News:Global Sodium Benzoate Industry Analysis Report 2015-2020 Now at DeepResearchReports.com 2Health News:Global Sodium Benzoate Industry Analysis Report 2015-2020 Now at DeepResearchReports.com 3Health News:The Aspen Club on Actively Aging: Telling a New Story on Aging 2Health News:Hair Transplant Contest Winner’s Surgery to be Streamed LIVE 2Health News:PartnerTech Named a Finalist for Gwinnett County Chamber of Commerce 2015 Movers & Makers Award 2Health News:PartnerTech Named a Finalist for Gwinnett County Chamber of Commerce 2015 Movers & Makers Award 3
... ... nominated, DENVER and DULUTH, Ga., Feb. 14 Winners of the,first-ever ... Western Veterinary Conference in Las Vegas on Feb. 19, 2008. The award,ceremony ... contest honors veterinarians for the outstanding work that they do on,behalf of ...
... N.Y., Feb. 14 Gentiva Health,Services, Inc. (Nasdaq: GTIV ), ... reported the,following financial results for the fourth quarter ended December 30, ... $313.4 million versus the fourth quarter ended ... million, or $0.31 per diluted share, versus ...
... of United States Patent, Application Covering its ... Natural Protein With Improved Anti-HCV Genotype ... S.A., a,biotechnology company dedicated to the discovery and development ... it has received notice of allowance from the United,States ...
... Valentines Day has,always conjured up images of eager boyfriends ... "I Love You." Over the decades, women have,become better ... others rather than simply accepting generic and, sometimes,short lived ... for Carl and Kristina of suburban Chicago. After,twelve years ...
... the nation,s top five hospitals, UCSF converts to Masimo SET pulse ... ... capabilities, IRVINE, Calif., Feb. ... Perfusion Pulse,Oximetry, today announced the completion of UCSF Medical Center,s,system-wide implementation ...
... Research has shown that the main metabolite of the ... tumours, but there has been no explanation for this ... open access journal Breast Cancer Research shows how DDT ... Michel Aube and colleagues from Universite Laval and Institut ...
Cached Medicine News:Health News:Winners of America's Best Vet Contest To Be Honored at Western Veterinary Conference in Las Vegas February 19; 2Health News:Winners of America's Best Vet Contest To Be Honored at Western Veterinary Conference in Las Vegas February 19; 3Health News:Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook 2Health News:Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook 3Health News:Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook 4Health News:Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook 5Health News:Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook 6Health News:Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook 7Health News:Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook 8Health News:Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook 9Health News:Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook 10Health News:Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook 11Health News:Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook 12Health News:Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook 13Health News:Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook 14Health News:Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook 15Health News:GenOdyssee Receives Notice of Allowance from U.S. Patent Office for Improved Interferon-Alpha Aimed at Hepatitis C 2Health News:GenOdyssee Receives Notice of Allowance from U.S. Patent Office for Improved Interferon-Alpha Aimed at Hepatitis C 3Health News:St. Valentine's Day Wishes: Perfume? Jewelry? Labiaplasty? 2Health News:The University of California at San Francisco Medical Center Pioneers System-wide Adoption of Masimo Rainbow SET Technology 2Health News:The University of California at San Francisco Medical Center Pioneers System-wide Adoption of Masimo Rainbow SET Technology 3Health News:The University of California at San Francisco Medical Center Pioneers System-wide Adoption of Masimo Rainbow SET Technology 4Health News:The University of California at San Francisco Medical Center Pioneers System-wide Adoption of Masimo Rainbow SET Technology 5Health News:How DDT metabolite disrupts breast cancer cells 2
(Date:2/26/2015)... Feb. 26, 2015  Lyric Pharmaceuticals Inc. today announced ... totaling $20.4 million. The financing, co-led by RiverVest Venture ... by Aperture Venture Partners. Lyric is ... David Wurtman , M.D., M.B.A., President & Chief Executive ... Medical Officer.  In 2014, Lyric closed a seed financing ...
(Date:2/26/2015)... Feb. 26, 2015 Columbia Laboratories, Inc. ... Company"), a specialty pharmaceutical company focused on the ... initiate a Phase II clinical trial for COL-1077, ... transvaginal pipelle-directed endometrial biopsy in the second quarter ... ("IND") submission feedback from the United States Food ...
(Date:2/26/2015)...  Great Basin Scientific, Inc. ("Great Basin") announced today ... of up to 2,724,000 units at $8.80 per Unit.  ... preferred stock and eight Series C warrants.  Each share ... four shares of common stock and each Series C ... stock at an exercise price of $2.55 per share.  ...
Breaking Medicine Technology:Columbia Laboratories to Initiate a Phase II Clinical Trial for COL-1077, Lidocaine Bioadhesive 10% Gel, in the Second Quarter of 2015 2Columbia Laboratories to Initiate a Phase II Clinical Trial for COL-1077, Lidocaine Bioadhesive 10% Gel, in the Second Quarter of 2015 3Great Basin Scientific, Inc. Announces Commencement of Public Offering 2Great Basin Scientific, Inc. Announces Commencement of Public Offering 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: